Finally, the improved survival with anti-CD80 as opposed to anti-CD86 confirms the results obtained with the knockout mice and the ability of anti-CD80 to rescue mice when given after the onset of sepsis suggests this is a potential therapeutic target as well. This evidence concerns the gene CD86 and Sepsis.